Skip to main content
. 2020 Nov;8(21):1368. doi: 10.21037/atm-20-1095

Table 3. Toxicity according to CTCAE4.0.

Type of toxic reaction Total (n=88) Pem + S-1 + Bev (n=21) Other regimens (n=67) P value
All grade 3/4 grade All grade 3/4grade All grade 3/4 grade All grade 3/4 grade
Blood system, n (%)
   Leukopenia 30 (34.1) 10 (11.4) 11 (52.4) 3 (14.3) 19 (28.4) 7 (10.4) 0.043* 0.929
   Neutropenia 30 (34.1) 14 (15.9) 11 (52.4) 6 (28.6) 19 (28.4) 8 (11.9) 0.043* 0.14
   Agranulocytosis 0 0 0 0 0 0
   Anemia 19 (21.6) 1 (1.1) 4 (19.0) 0 15 (22.4) 1 (1.5) 0.983 0.761
   Thrombocytopenia 16 (18.2) 2 (2.3) 5 (23.8) 0 11 (16.4) 2 (3.0) 0.658 0.578
   Bleeding 2 (2.3) 0 1 (4.8) 0 1 (1.5) 0 0.368
Digestive system, n (%)
   Loss of appetite 5 (5.7) 0 2 (9.5) 0 3 (4.5) 0 0.74
   Nausea and vomiting 1 (1.1) 0 0 0 1 (1.5) 0 0.761
   Diarrhea 1 (1.1) 0 0 0 1 (1.5) 0 0.761
   Elevated alanine aminotransferase 12 (13.6) 0 4 (19.0) 0 8 (11.9) 0 0.643
   Elevated aspartate aminotransferase 20 (22.7) 0 4 (19.0) 0 16 (23.9) 0 0.871
   Elevated bilirubin 6 (6.8) 0 2 (9.5) 0 4 (6.0) 0 0.946
Urinary system, n (%)
   Elevated serum creatinine 1 (1.1) 0 0 0 1 (1.5) 0 0.761
   Elevated blood urea nitrogen 2 (2.3) 0 0 0 2 (3.0) 0 0.578
   Proteinuria 10 (11.4) 0 6 (28.6) 0 4 (6.0) 0 0.014*
   Hematuria 6 (6.8) 0 2 (9.5) 0 4 (6.0) 0 0.946
Other regimens, n (%)
   Fatigue 2 (2.3) 0 1 (4.8) 0 1 (1.5) 0 0.368
   Rash 3 (3.4) 0 1 (4.8) 0 2 (3.0) 0 0.423
   Oral ulcer 1 (1.1) 0 0 0 1 (1.5) 0 0.761
   Edema 1 (1.1) 0 0 0 1 (1.5) 0 0.761

*, P<0.05. Pem, Pemetrexed; Bev, Bevacizumab.